EDMUNDO RIVERA: Open Payments
NPI 1437231115 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,529 in 93 payments from 18 companies in 2025. Trend: 2023 $10,509 · 2024 $2,400 · 2025 $3,529
Food & beverage: $3,268Consulting: $150Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $755 |
| E.R. Squibb & Sons, L.L.C. | 11 | $492 |
| Neurocrine BioSciences, Inc. | 9 | $396 |
| Teva Pharmaceuticals USA, Inc. | 8 | $352 |
| Otsuka America Pharmaceutical, Inc. | 4 | $288 |
| Janssen Pharmaceuticals, Inc | 8 | $252 |
| ABBVIE INC. | 11 | $249 |
| Vanda Pharmaceuticals Inc. | 4 | $198 |
| JAZZ PHARMACEUTICALS INC. | 3 | $195 |
| Axsome Therapeutics, Inc. | 3 | $82 |
Products named: CAPLYTA, COBENFY, INGREZZA, REXULTI, VRAYLAR, INVEGA SUSTENNA, AUSTEDO XR, XYWAV.
Industry payments across FL — which companies pay providers there.
